The Taiwan Precision Medicine Initiative (TPMI) is a partnership between Academia Sinica and top medical centers in Taiwan to bring genetic information into clinical practice. By profiling 1 million participants with a set of genetic markers designed for Taiwan, we aim to optimize patient care by preventing dangerous drug side-effects, early cancer screening for those at high risk, and encouraging life-style changes for those at risk for other serious diseases.

Cumulatively, our center has collected the DNA of 15,000 individuals and analyzed the genetic results of 10,000 individuals.

Go to top